MetaCap

NeuroSense Therapeutics Congress Trades

NASDAQ: NRSNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.66-0.08 (-2.14%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0
Sales
0
Politicians trading
0
Latest trade
Aug 1, 2025

NeuroSense Therapeutics Congress trading summary

Members of Congress have disclosed 4 transactions in NeuroSense Therapeutics (NRSN) stock, reported by 1 politician. No NRSN trades were reported with a transaction date in the past 12 months. The most active trader is Lee Zeldin (4).

The latest reported trade is a purchase by Lee Zeldin dated Aug 1, 2025 and disclosed on May 27, 2026. The most common reported amount is $1,001 – $15,000; disclosures list value ranges, not exact amounts.

Summary generated from market data by MetaCap's automated system. Methodology

Politicians trading NRSN

NRSN trades by members of Congress

NeuroSense Therapeutics stock trades disclosed by members of Congress
PoliticianTypeAmountTradedFiling
Lee ZeldinRExecutiveBuy$1,001 – $15,000Aug 1, 2025Filing for Lee Zeldin NRSN trade
Lee ZeldinRExecutiveBuy$1,001 – $15,000Aug 1, 2025Filing for Lee Zeldin NRSN trade
Lee ZeldinRExecutiveSell$1,001 – $15,000May 13, 2025Filing for Lee Zeldin NRSN trade
Lee ZeldinRExecutiveSell$1,001 – $15,000May 13, 2025Filing for Lee Zeldin NRSN trade

Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction.

Related

Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction. Disclosures are shown as filed and are not a recommendation to buy or sell NRSN. How Congress trading data works